NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
5 hedge funds and large institutions have $39K invested in Northwest Biotherapeutics, Inc. Common stock in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SAM
1
Seelaus Asset Management
Chatham,
New Jersey
| $14K | 50,000 | – | – |
|
|
WPP
2
Whalerock Point Partners
Providence,
Rhode Island
| $14K | 51,000 | +11,000 | +28% |
|
|
LDB
3
Lee, Danner & Bass
Nashville,
Tennessee
| $5K | 20,000 | – | – |
|
|
MPI
4
Mairs & Power Inc
St Paul,
Minnesota
| $3K | 12,500 | – | – |
|
5
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $3K | 9,200 | +9,200 | New |
|
|
HNB
6
Huntington National Bank
Columbus,
Ohio
| – | – | -25,000 | Closed |
|
|
HAG
7
HighPoint Advisor Group
Downers Grove,
Illinois
| – | – | -19,450 | Closed |
|